Reduction of Cardiovascular Risk through Angiotensin II Type 1 Receptor Antagonism: Focus on Olmesartan Medoxomil

By Enrico Agabiti Rosei  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 4, 2008-01 ,pp. : 231-243

Adis International

Access to resources Recommend Favorite

Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

By Brillante Divina Gracilla   O'Sullivan Anthony John   Brillante Ruby Esmeralda   Howes Laurence Guy  

Blood Pressure, Vol. 18, Iss. 3, 2009-06 ,pp. : 142-148

Informa Healthcare

Access to resources Recommend Favorite

Dual Effects of Angiotensin II Type 2 Receptor on Cardiovascular Hypertrophy

By Inagami T.   Senbonmatsu T.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 8, 2001-11 ,pp. : 324-328

Elsevier

Access to resources Recommend Favorite

Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation

By Isobe Aki   Takeda Takashi   Sakata Masahiro   Miyake Asako   Yamamoto Toshiya   Minekawa Ryoko   Nishimoto Fumihito   Oskamoto Yoko   Walker Cheryl Lyn   Kimura Tadashi  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 440-446

Oxford University Press

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept

By JOHNSTON COLIN I.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite